Jazz Pharmaceuticals (NASDAQ: JAZZ) grants 1,605 RSUs to director
Rhea-AI Filing Summary
RIEDEL NORBERT G reported acquisition or exercise transactions in this Form 4 filing.
Jazz Pharmaceuticals plc director Norbert G. Riedel received a grant of 1,605 restricted stock units on August 5, 2026 under the 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Each unit represents a contingent right to one ordinary share and will vest in full on July 23, 2027, subject to continuous service and other conditions. Following the award, 8,629 ordinary shares were reported as beneficially owned by the NORBERT G. RIEDEL 2023 TRUST, and a separate indirect holding entry shows 10,630 ordinary shares held by trust.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 1,605 shares
Net Buy
2 txns
Insider
RIEDEL NORBERT G
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Ordinary Shares F1, F2 | 1,605 | $0.00 | $0.00 |
| holding | Ordinary Shares | -- | -- | -- |
Holdings After Transaction:
Ordinary Shares — 8,629 shares (Direct);
Ordinary Shares — 10,630 shares (Indirect, by Trust)
Footnotes (2)
- F1. These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on July 23, 2027.
- F2. Shares beneficially owned by NORBERT G. RIEDEL 2023 TRUST, an entity owned and controlled by the reporting person and his immediate family.
Key Figures
Restricted stock units granted: 1,605 units
Vesting date: July 23, 2027
Trust beneficial ownership after grant: 8,629 shares
+2 more
5 metrics
Restricted stock units granted
1,605 units
Grant to director Norbert G. Riedel on August 5, 2026
Vesting date
July 23, 2027
RSUs vest in full on this date subject to conditions
Trust beneficial ownership after grant
8,629 shares
Ordinary shares beneficially owned by NORBERT G. RIEDEL 2023 TRUST
Indirect trust holdings reported
10,630 shares
Ordinary shares held indirectly by trust after reported transactions
Transaction price per share
$0.0000
Equity grant reported at zero cash price per share
Key Terms
restricted stock units, Non-Employee Directors Stock Award Plan, contingent right, beneficially owned
4 terms
restricted stock units financial
"These restricted stock units are granted pursuant to the Issuer's 2007 Amended..."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Non-Employee Directors Stock Award Plan financial
"granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan"
contingent right financial
"Each restricted stock unit represents a contingent right to receive one ordinary share"
beneficially owned financial
"Shares beneficially owned by NORBERT G. RIEDEL 2023 TRUST, an entity owned and controlled..."
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What did director Norbert G. Riedel acquire in this Form 4 for JAZZ?
Director Norbert G. Riedel acquired 1,605 restricted stock units of Jazz Pharmaceuticals. The grant was made on August 5, 2026 under the company’s 2007 Amended and Restated Non-Employee Directors Stock Award Plan as equity compensation.
When do Norbert G. Riedel’s 1,605 RSUs in JAZZ vest?
The 1,605 restricted stock units will vest in full on July 23, 2027. Vesting is subject to Riedel’s continuous service and certain additional conditions, after which each unit converts into one ordinary share.
What indirect holdings by trust are disclosed for JAZZ in this filing?
A separate holding entry reports 10,630 ordinary shares held indirectly "by Trust." This reflects additional trust-related ownership in Jazz Pharmaceuticals, distinct from the 8,629 shares also reported as beneficially owned by the 2023 trust.
Were Norbert G. Riedel’s JAZZ equity transactions under a Rule 10b5-1 plan?
The filing’s Rule 10b5-1 checkbox is not marked as affirmative. The grant is reported as equity compensation under the non-employee directors stock award plan, not as a trade executed pursuant to a Rule 10b5-1 trading plan.